MedTrace Logo

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

NCT02421705 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99999999

Last updated 2023-02-08

No results posted yet for this study

Summary

Aim:

More insight in pathogenesis of IBS and IBD. Samples are collected in context of an European research project.

Conditions

  • IBS
  • Ulcerative Colitis, Active
  • Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms)
  • Healthy Controls
  • Crohn's Disease, Active
  • Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)

Interventions

OTHER

Sample collection

Collection of blood, feces samples, sample of nasal mucosa and biopsies (rectum and colon descendens), questionnaires and performance of rectal sensitivity measurement (barostat), MR scan of brain and transit measurement of colon

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Guy Boeckxstaens, MD · Catholic University Leuven and Universitary Hospitals Leuven

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2099-01-31
Completion
2099-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02421705 on ClinicalTrials.gov